The New ClinicAll App Aims to Make Hospital Visits Hassle-Free for Patients

Food and Healthcare Press Releases Tuesday April 17, 2018 07:24
NEUSS, Germany--17 Apr--PRNewswire/InfoQuest
Benefit from the lastest developments in health technology with the ClinicAll App
Developed for iOS and Android, the new ClinicAll app lets previously unfulfilled wishes come true, giving users full access to a wide range of services.
(Photo: https://mma.prnewswire.com/media/676359/ClinicAll_app.jpg )

ClinicAll has already been successful in providing digitalized solutions for clinics. This expertise has led to the idea of making all the possibilities of this new technology available to all users - conveniently on any smartphone or tablet.

The ClinicAll app makes sure users are the center of attention

During a hospital stay, the ClinicAll app enables the use of TV, Internet, and to call up all hospital information such as treatment appointments, meals, room lighting or bed control. Doctors and staff can inform the patient about upcoming visits via push messages. The app can also be used to call a nurse at any time - making it easy and uncomplicated to communicate with hospital staff.

After the stay, the ClinicAll app provides interesting news and information on the topics of health technology, ClinicAll, affiliated clinics and partners.
Available now in the App store - discover all the benefits live at conhIT 2018:
The ClinicAll app has now been released in the Android and iOS App stores. To date, no other supplier on the market has been able to realize an app for patients and clinics with a comparable range of features.
In order to install, search through the App store for "ClinicAll App".
The new ClinicAll app will be shown to industry representatives for the first time in our own virtual hospital set-up at conhIT 2018 - with some first applications.
Contact:
ClinicAll Germany GmbH,
Lea Kelic,
+49-2131 52813-30
lk@clinicall.de
Source: ClinicAll

Latest Press Release

The Menarini Group Announces Meropenem/vaborbactam European Marketing Authorization

- Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections - The first combination of a carbapenem and a beta-lactamase inhibitor approved for clinical use in...

Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

- FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of first clinical data in BTC - BTC is a group of rare, aggressive...

Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities

- Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics - Cloud-based in silico platform that screens small molecules to determine polypharmacological profiles - Evaluation to include...

Vitality-linked Insurers to Get 100 million People 20% More Active by 2025

Building on the results of the largest behaviour change study on physical activity, Vitality and its global network of insurers have collectively committed to improving the health of millions over the next seven years. This is in line with the World...

World Congress of Cardiology Cardiovascular Health 2018 Opens in Dubai

- Professor David Wood, President of the World Heart Federation, welcomes more than 5000 cardiologists, doctors, nurses, and health and policy experts from around the world to Dubai for WCC 2018 at a time when the opportunities for a sustainable impact...

Related Topics